ST BaiLing (002424.SZ): The trial of the new process route for the TianTai project has been successfully completed.

Gelonghui November 1st 丨 ST BaiLing (002424.SZ) stated on the investor interaction platform that the new process route trial for the Terfenadine project has successfully concluded and is now undergoing validation. If successful, samples can be produced using the new process to conduct drug interaction clinical trials.

Gelonghui FinanceNov 1 03:28 ET

ST Bering: Third Quarter 2024 Report

SZSIOct 25 12:00 ET · Announcements

ST Balin (002424.SZ) released its performance for the first three quarters, with a net income of 88.216 million yuan, a 37.20% year-on-year decrease.

special treat BaiLing (002424.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...

Zhitong FinanceOct 25 07:33 ET

Is Guizhou Bailing Group Pharmaceutical (SZSE:002424) Using Too Much Debt?

Simply Wall StOct 24 19:57 ET

ST Bering: Corrections to the 2023 Annual Report

SZSIOct 11 12:00 ET · Announcements

Investors in Guizhou Bailing Group Pharmaceutical (SZSE:002424) From Five Years Ago Are Still Down 64%, Even After 9.8% Gain This Past Week

Simply Wall StSep 27 22:41 ET